These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 17446106)
1. Structural investigation of PAP derivatives by CoMFA and CoMSIA reveals novel insight towards inhibition of Bcr-Abl oncoprotein. San Juan AA J Mol Graph Model; 2007 Sep; 26(2):482-93. PubMed ID: 17446106 [TBL] [Abstract][Full Text] [Related]
2. Insight into the structural requirements of urokinase-type plasminogen activator inhibitors based on 3D QSAR CoMFA/CoMSIA models. Bhongade BA; Gadad AK J Med Chem; 2006 Jan; 49(2):475-89. PubMed ID: 16420035 [TBL] [Abstract][Full Text] [Related]
3. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. Hou T; Zhu L; Chen L; Xu X J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563 [TBL] [Abstract][Full Text] [Related]
4. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies. Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164 [TBL] [Abstract][Full Text] [Related]
5. CoMFA and CoMSIA studies on thiazolidin-4-one as anti-HIV-1 agents. Murugesan V; Prabhakar YS; Katti SB J Mol Graph Model; 2009 Feb; 27(6):735-43. PubMed ID: 19117780 [TBL] [Abstract][Full Text] [Related]
6. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments. Pandey G; Saxena AK J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198 [TBL] [Abstract][Full Text] [Related]
7. 3D-QSAR CoMFA, CoMSIA studies on substituted ureas as Raf-1 kinase inhibitors and its confirmation with structure-based studies. Thaimattam R; Daga P; Rajjak SA; Banerjee R; Iqbal J Bioorg Med Chem; 2004 Dec; 12(24):6415-25. PubMed ID: 15556759 [TBL] [Abstract][Full Text] [Related]
8. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114 [TBL] [Abstract][Full Text] [Related]
9. Rational design based on bioactive conformation analysis of pyrimidinylbenzoates as acetohydroxyacid synthase inhibitors by integrating molecular docking, CoMFA, CoMSIA, and DFT calculations. He YZ; Li YX; Zhu XL; Xi Z; Niu C; Wan J; Zhang L; Yang GF J Chem Inf Model; 2007; 47(6):2335-44. PubMed ID: 17887745 [TBL] [Abstract][Full Text] [Related]
10. Quantitative structure-activity relationships for a series of inhibitors of cruzain from Trypanosoma cruzi: molecular modeling, CoMFA and CoMSIA studies. Trossini GH; Guido RV; Oliva G; Ferreira EI; Andricopulo AD J Mol Graph Model; 2009 Aug; 28(1):3-11. PubMed ID: 19376735 [TBL] [Abstract][Full Text] [Related]
12. 3D-QSAR studies of boron-containing dipeptides as proteasome inhibitors with CoMFA and CoMSIA methods. Zhu YQ; Lei M; Lu AJ; Zhao X; Yin XJ; Gao QZ Eur J Med Chem; 2009 Apr; 44(4):1486-99. PubMed ID: 18771818 [TBL] [Abstract][Full Text] [Related]
13. CoMFA and CoMSIA 3D QSAR analysis on N1-arylsulfonylindole compounds as 5-HT6 antagonists. Doddareddy MR; Cho YS; Koh HY; Pae AN Bioorg Med Chem; 2004 Aug; 12(15):3977-85. PubMed ID: 15246074 [TBL] [Abstract][Full Text] [Related]
14. Towards predictive inhibitor design for the EGFR autophosphorylation activity. San Juan AA Eur J Med Chem; 2008 Apr; 43(4):781-91. PubMed ID: 17689836 [TBL] [Abstract][Full Text] [Related]
15. Structural requirements of pyrido[2,3-d]pyrimidin-7-one as CDK4/D inhibitors: 2D autocorrelation, CoMFA and CoMSIA analyses. Caballero J; Fernández M; González-Nilo FD Bioorg Med Chem; 2008 Jun; 16(11):6103-15. PubMed ID: 18468903 [TBL] [Abstract][Full Text] [Related]
16. Development of new CoMFA and CoMSIA 3D-QSAR models for anti-inflammatory phthalimide-containing TNFalpha modulators. Avila CM; Romeiro NC; da Silva GM; Sant'Anna CM; Barreiro EJ; Fraga CA Bioorg Med Chem; 2006 Oct; 14(20):6874-85. PubMed ID: 16843662 [TBL] [Abstract][Full Text] [Related]
17. An investigation of structurally diverse carbamates for acetylcholinesterase (AChE) inhibition using 3D-QSAR analysis. Roy KK; Dixit A; Saxena AK J Mol Graph Model; 2008 Sep; 27(2):197-208. PubMed ID: 18515163 [TBL] [Abstract][Full Text] [Related]
19. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor. Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163 [TBL] [Abstract][Full Text] [Related]